Ribosomal protein L13 pseudogene 12 (RPL13P12)

Ribosomal protein L13 pseudogene 12 (RPL13P12) is a processed pseudogene in the human genome, meaning it is a non-coding copy of the gene for ribosomal protein L13. Unlike the functional ribosomal protein genes, RPL13P12 is not translated into a functional protein and does not encode an enzyme, receptor, transporter, or other typical drug target protein. Pseudogenes such as RPL13P12 can sometimes be transcribed, but generally do not possess biological activity or clear pathogenic roles, and there is no evidence of direct involvement in disease or a validated role as a biomarker. There is no evidence that RPL13P12 is a therapeutic target, nor that drugs interact with it or that it is used in patient selection or efficacy monitoring. This designation as a pseudogene means it is primarily of genomic or evolutionary interest—not therapeutic or diagnostic utility. RPL13P12 should not be confused with the functional ribosomal protein L13, which is encoded by RPL13 and is a part of the 60S ribosomal subunit. RPL13P12 is often listed in gene databases and catalogs for completeness, but is not regarded as a protein-coding gene or a target for therapy. There are no reported diseases, biological functions, biomarkers, safety concerns, or drug interactions associated with RPL13P12. The entry is "incorrect" as a therapeutic target due to its pseudogene status, not due to spelling or missing data.

Other names

RPL13_4_1521RPL13P12